{"id":"https://openalex.org/W2035948587","doi":"https://doi.org/10.1016/j.bmcl.2009.07.020","title":"Novel CXCR3 antagonists with a piperazinyl-piperidine core","display_name":"Novel CXCR3 antagonists with a piperazinyl-piperidine core","publication_year":2009,"publication_date":"2009-07-10","ids":{"openalex":"https://openalex.org/W2035948587","doi":"https://doi.org/10.1016/j.bmcl.2009.07.020","mag":"2035948587","pmid":"https://pubmed.ncbi.nlm.nih.gov/19647429"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2009.07.020","doi":"https://doi.org/10.1016/j.bmcl.2009.07.020","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.07.020","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Brian F. McGuinness","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian F. McGuinness","raw_affiliation_strings":["Ligand Pharmaceuticals, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA. bmcguinness@ligand.com","Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA. bmcguinness@ligand.com","institution_ids":["https://openalex.org/I4210117915"]},{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006690232","display_name":"Carolyn DiIanni Carroll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn DiIanni Carroll","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041665098","display_name":"Lisa Guise Zawacki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Guise Zawacki","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048710055","display_name":"Guizhen Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guizhen Dong","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103395633","display_name":"Cangming Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cangming Yang","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113669931","display_name":"Doug W. Hobbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doug W. Hobbs","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080691552","display_name":"Biji Jacob-Samuel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Biji Jacob-Samuel","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101045345","display_name":"James W. Hall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117915","display_name":"Ligand Pharmaceuticals (United States)","ror":"https://ror.org/02ed5f444","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117915"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James W. Hall","raw_affiliation_strings":["Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ligand Pharmaceuticals\u2020, 3000 Eastpark Boulevard, Cranbury, NJ 08512, USA","institution_ids":["https://openalex.org/I4210117915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000798760","display_name":"Chung\u2010Her Jenh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chung-Her Jenh","raw_affiliation_strings":["Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083758750","display_name":"Joseph A. Kozlowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph A. Kozlowski","raw_affiliation_strings":["Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026966644","display_name":"G. Anilkumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gopinadhan N. Anilkumar","raw_affiliation_strings":["Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022412045","display_name":"Stuart B. Rosenblum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stuart B. Rosenblum","raw_affiliation_strings":["Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth NJ 07033 USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.4949,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.89015152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"19","issue":"17","first_page":"5205","last_page":"5208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cxcr3-antagonist","display_name":"CXCR3 antagonist","score":0.9769999980926514},{"id":"https://openalex.org/keywords/combinatorial-libraries","display_name":"combinatorial libraries","score":0.6190000176429749},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7630000114440918},{"id":"https://openalex.org/keywords/hit-optimization","display_name":"hit optimization","score":0.43700000643730164},{"id":"https://openalex.org/keywords/solid-phase-synthesis","display_name":"solid-phase synthesis","score":0.6000000238418579},{"id":"https://openalex.org/keywords/wet-chemical-synthesis","display_name":"wet chemical synthesis","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.9302499294281006},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9128327369689941},{"id":"https://openalex.org/C2776201271","wikidata":"https://www.wikidata.org/wiki/Q409292","display_name":"Piperazine","level":2,"score":0.7271151542663574},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5255012512207031},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.47478431463241577},{"id":"https://openalex.org/C2776469878","wikidata":"https://www.wikidata.org/wiki/Q2026994","display_name":"Solid-phase synthesis","level":3,"score":0.45259830355644226},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4500935971736908},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.4415295720100403},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.244826078414917},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20208483934402466},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.10308626294136047},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.07347005605697632}],"mesh":[{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020650","descriptor_name":"Combinatorial Chemistry Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2009.07.020","doi":"https://doi.org/10.1016/j.bmcl.2009.07.020","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.07.020","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:19647429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19647429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W169887259","https://openalex.org/W1528069886","https://openalex.org/W1795191204","https://openalex.org/W1986195187","https://openalex.org/W2009364468","https://openalex.org/W2015863707","https://openalex.org/W2023088800","https://openalex.org/W2028326650","https://openalex.org/W2035093405","https://openalex.org/W2041873149","https://openalex.org/W2066091753","https://openalex.org/W2069149379","https://openalex.org/W2069185051","https://openalex.org/W2070491893","https://openalex.org/W2071917777","https://openalex.org/W2091586967","https://openalex.org/W2115289037","https://openalex.org/W2140537109","https://openalex.org/W2144940586","https://openalex.org/W4252036388"],"related_works":["https://openalex.org/W2066301424","https://openalex.org/W2041787575","https://openalex.org/W2073246701","https://openalex.org/W2058022664","https://openalex.org/W2096973404","https://openalex.org/W1971676818","https://openalex.org/W2028383100","https://openalex.org/W2055463589","https://openalex.org/W2009364468","https://openalex.org/W2025617572"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}